- Report
- August 2025
- 199 Pages
Global
From €3146EUR$3,545USD£2,718GBP
€3496EUR$3,939USD£3,020GBP
- Report
- April 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,443GBP
- Report
- August 2025
- 588 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- August 2025
- 378 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- December 2024
- 200 Pages
Global
From €3328EUR$3,750USD£2,875GBP
- Report
- July 2025
- 350 Pages
Global
From €4392EUR$4,949USD£3,795GBP
- Report
- June 2025
- 210 Pages
Global
From €4433EUR$4,995USD£3,830GBP
- Report
- January 2025
- 209 Pages
Global
From €4433EUR$4,995USD£3,830GBP
From €6656EUR$7,500USD£5,751GBP
- Report
- December 2024
- 436 Pages
Global
From €3550EUR$4,000USD£3,067GBP
- Report
- August 2024
- 112 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- July 2025
- 84 Pages
Europe
From €5321EUR$5,995USD£4,597GBP
- Report
- July 2025
- 73 Pages
North America
From €5321EUR$5,995USD£4,597GBP
- Report
- July 2025
- 80 Pages
Asia Pacific
From €5321EUR$5,995USD£4,597GBP
- Report
- January 2022
- 56 Pages
Global
From €3328EUR$3,750USD£2,875GBP
- Report
- August 2023
- 146 Pages
Global
From €1677EUR$1,890USD£1,449GBP
- Report
- July 2020
- 118 Pages
Global
From €1500EUR$1,690USD£1,296GBP

The Cardiac Marker market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs and other treatments for cardiovascular diseases. Cardiac markers are substances that are released into the bloodstream when the heart is damaged or stressed. These markers can be used to diagnose and monitor the progression of cardiovascular diseases, such as heart attack, stroke, and congestive heart failure. The market is driven by the increasing prevalence of cardiovascular diseases, the growing demand for early diagnosis and treatment, and the development of new technologies.
The Cardiac Marker market is highly competitive, with a number of large and small companies operating in the space. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more